Back

Safety of uninterrupted dabigatran in cardiovascular interventions in the GLORIA-AF registry program

18 March 2018 (15:12 - 15:21)
Organised by:
Congress Presentation Part of: What is new in atrial fibrillation? Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring.
Doctor P. Papakonstantinou (Dublin, IE)
Slides Video
Presentation thumbnail
Aetiology-dependent atrial remodelling - a translational approach to characterise disease specific atrial cardiomyopathies in arterial hypertension and diabetic mellitus
Doctor A. Bukowska (Magdeburg, DE)
Abstract Slides Video
Presentation thumbnail
Baseline echocardiography-indicated impaired atrial function predicts reoccurrence and thromboembolic risks after catheter ablation of atrial fibrillation
Doctor S. Chu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
PR interval prolongation as intermediate phenotype for atrial fibrillation: Association with echocardiographic parameters and biomarkers (the LIFE-Adult-Study)
Doctor J. Kornej (Boston, US)
Abstract
Presentation thumbnail
Trends in hospital admissions for atrial fibrillation in Australia: a relentless rise
Ms C. Gallagher (Adelaide, AU)
Abstract

Access the full session

Session thumbnail
What is new in atrial fibrillation?

The Event

Event poster

EHRA 2018

18 March 2018 15:12 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources